Aura Biosciences, Inc. (AURA)

NASDAQ: AURA · IEX Real-Time Price · USD
17.81 -0.35 (-1.93%)
Jan 21, 2022 4:00 PM EST - Market closed

Cash Flow Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year20202019
Net Income
-22.21-24.2
Depreciation & Amortization
0.830.51
Share-Based Compensation
0.740.51
Other Operating Activities
-3.682.52
Operating Cash Flow
-24.32-20.67
Capital Expenditures
-0.77-2.22
Investing Cash Flow
-0.77-2.22
Share Issuance / Repurchase
0.160.06
Debt Issued / Paid
-0.03-0.04
Other Financing Activities
9.9139.71
Financing Cash Flow
10.0439.73
Net Cash Flow
-15.0616.84
Free Cash Flow
-25.09-22.89
Free Cash Flow Per Share
-4.99-4.94
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).